Lord, Abbett & Co’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-75,758
| Closed | -$17.8M | – | 886 |
|
|
2015
Q4 | $17.8M | Buy |
75,758
+54,206
| +252% | +$12.7M | 0.05% | 462 |
|
|
2015
Q3 | $3.41M | Sell |
21,552
-95,276
| -82% | -$15.1M | 0.01% | 793 |
|
|
2015
Q2 | $44.2M | Sell |
116,828
-38,307
| -25% | -$14.5M | 0.12% | 281 |
|
|
2015
Q1 | $64.9M | Sell |
155,135
-22,851
| -13% | -$9.55M | 0.16% | 180 |
|
|
2014
Q4 | $48.7M | Buy |
177,986
+73,504
| +70% | +$20.1M | 0.12% | 241 |
|
|
2014
Q3 | $20.3M | Sell |
104,482
-8,016
| -7% | -$1.56M | 0.05% | 489 |
|
|
2014
Q2 | $27.5M | Buy |
112,498
+81,301
| +261% | +$19.9M | 0.06% | 439 |
|
|
2014
Q1 | $8.27M | Sell |
31,197
-36,374
| -54% | -$9.64M | 0.02% | 700 |
|
|
2013
Q4 | $24.5M | Sell |
67,571
-34,613
| -34% | -$12.6M | 0.05% | 475 |
|
|
2013
Q3 | $54.3M | Sell |
102,184
-20,987
| -17% | -$11.2M | 0.13% | 228 |
|
|
2013
Q2 | $28.8M | Buy |
+123,171
| New | +$28.8M | 0.07% | 422 |
|